Skip to main content
. Author manuscript; available in PMC: 2018 Sep 29.
Published in final edited form as: Circ Res. 2017 Sep 29;121(8):896–898. doi: 10.1161/CIRCRESAHA.117.311865

Figure.

Figure

In vivo gene editing to restore dystrophin’s reading frame has been applied to both the mdx (left) and mdx4cv models (right), which have mutations either in exon 23 or 53, respectively. El Rafaey et al. now used mdx mice in combination with heterozygous loss of utrophin (Utrn+/−) to demonstrate improved cardiac function after dystrophin gene editing.